Seminars in Oncology
Volume 34, Supplement 5 , Pages S29-S34, December 2007

Purine Nucleoside Phosphorylase Inhibition as a Novel Therapeutic Approach for B-Cell Lymphoid Malignancies

  • Richard R. Furman

      Affiliations

    • CLL Research Center, and the Center for Lymphoma and Myeloma, Weill Cornell Medical Center, New York, NY.
    • Corresponding Author InformationAddress reprint requests to Richard R. Furman, MD, Division of Hematology and Oncology, Weill Cornell Medical College, 525 East 68th St, New York, NY 10021.
    • ,
  • Dieter Hoelzer

      Affiliations

    • Klinklum der JW Goethe Universitat, Frankfurt, Germany.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00223-0

doi:10.1053/j.seminoncol.2007.11.004

Seminars in Oncology
Volume 34, Supplement 5 , Pages S29-S34, December 2007

Article Tools

* Image Usage & Resolution